Navigation Links
COMEDY CENTRAL(R) Announces Live On-Air Charity Special 'Night Of Too Many Stars: An Overbooked Benefit For Autism Education' Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET
Date:3/10/2008

nc.com">nightoftoomanystars@eventassociatesinc.com. All VIP Benefit tickets, which begin at $1,250 per person, include access to the after-party with talent.

Performers raising money to help ease the severe shortage of effective schools and education programs for autistic children and adults, include Will Arnett, Matthew Broderick, Steve Carell, Stephen Colbert, Susie Essman, Will Ferrell, Tina Fey, Jonah Hill, Kevin James, Rosie O'Donnell, Amy Poehler, Conan O'Brien, Adam Sandler, Sarah Silverman, Triumph The Insult Comic Dog and many more talent to be announced.

Beginning on Monday, April 14, "Night Of Too Many Stars" will be available for download on iTunes and xBox Live Marketplace for 30 days. All proceeds from the $1.99 download will go directly to the charity. In addition, comedycentral.com will stream the entire broadcast online on Monday, April 14. Users will have the opportunity to donate to the charity via the Web site.

"Night Of Too Many Stars" is sponsored by Toyota, Old Spice and SoBe Life Water.

The October 2006 "Night Of Too Many Stars: An Overbooked Benefit For Autism Education" raised more than $2.5 million.

"Night Of Too Many Stars" will benefit a variety of Autism education programs around the country. The funds raised will support educational facilities that have recently opened or are about to open their doors, along with those already well-established model schools that are now developing innovative programs to provide vocational and life skills for adults with autism. Proceeds will also support outreach programs that provide training and consultation to families of very young children in their homes. Additionally, a portion of the proceeds will benefit Autism Speaks, the nation's leading autism advocacy group.

COMEDY CENTRAL, the only all-comedy network, currently is seen in more than 91 million homes nationwide. COMEDY CENTRAL is owned by, and is a registered trademark of, Comedy Partners, a whol
'/>"/>

SOURCE COMEDY CENTRAL
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Almost Family Announces Record Quarterly and Year End Results
2. MHA Announces Initial Results of the Specialty Pharmacy Member Profile Initiative
3. Webcast Alert: EP MedSystems Announces EP MedSystems Fourth Quarter 2007 Earnings Conference Call Webcast
4. NBTY to Webcast Presentation at Bank of America Consumer Conference: Announces Preliminary Sales and the Repurchase of 6.1 Million Shares
5. Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer
6. HCA Announces Final Results for its Debt Tender Offer
7. Universal Health Realty Income Trust Announces Dividend
8. Genta Announces Licensing Agreement for Worldwide Development and Commercialization of a Leading Oral Taxane, Tesetaxel
9. Novavax Announces Release Date of 2007 Fourth Quarter, Full Year Financial Results and Investor Conference Call
10. Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference
11. Susan G. Komen for the Cure(R) Announces Global Promise Fund to Help Women Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:The Army Awards Follow-On Contract for Autonomous Airway Management to Energid Technologies 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8Steaz Launches Organic Zero Calorie Sparkling Line 59893 1Steaz Launches Organic Zero Calorie Sparkling Line 59893 2Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 1Henry Schein to Webcast Third Quarter 2009 Conference Call Wednesday November 4 at 10 A M EST 59891 2Bioidentical Hormones a True Prevention for Breast Cancer 59889 1Bioidentical Hormones a True Prevention for Breast Cancer 59889 2